Skip to main content

Raven Sun


[email protected]



Raven focuses her practice on corporate and securities law, capital markets transactions, corporate finance, and general corporate matters. She has experience drafting documents for public and private securities offerings, special purpose acquisition company (SPAC) offerings, and mergers and acquisitions. She also performs due diligence, assists clients with SEC filing and reporting obligations, and counsels companies on corporate governance issues. Raven works with public and private companies in a variety of industries, including life sciences, technology, and health care.

Prior to joining Mintz, Raven was an associate at a New York City–based boutique corporate and securities law firm, where she worked on corporate transactions and advised clients on SEC compliance and corporate governance matters. Earlier, she was a legal intern in the New York office of a Chinese corporate law firm.

During law school, Raven served as a summer legal intern with a full-service law firm in Beijing, China and a clerk in a public prosecutor’s office in Beijing.


SEC Adopts Amendments to Section 13 Reporting Requirements

October 25, 2023 | Alert | By Anne Bruno, Daniel T. Kajunski, Raven Sun

Read more
Read less

News & Press

Press Release Thumbnail
Mintz Members John Rudy and Matthew T. Simpson led the team that advised ArriVent Biopharma, Inc. on its initial public offering (IPO) on the Nasdaq Global Market. This was the second biotech IPO of 2024. ArriVent is a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics.
Read less